New Testing Strips to Make Rapid Antigen Testing as Powerful as PCR Testing
By LabMedica International staff writers Posted on 06 Mar 2024 |
During the onset of the pandemic, individuals experiencing symptoms had to endure lengthy queues for lab-based PCR testing and then wait around two days for the results, to confirm if they were infected with the COVID-19 virus. This process was not only inconvenient but also involved complex and costly logistics, contributing to testing delays and increasing the risk of spreading the disease. Now, a newly developed biosensing technology enables the creation of gene test strips that can match the quality of traditional lab-based tests.
The new technology developed by a team of biomedical engineers at UNSW Sydney (Sydney, Australia) offers test strips that are as accurate as lab-based PCR tests, with the added advantage of quick, on-site disease detection. Described by the researchers as having “PCR in your pocket,” this advancement holds potential for broad applications in biomedical and environmental diagnostics across various sectors, including food, agriculture, and biosafety management. The technology allows for the detection of specific gene sequences at room temperature, using test strips that resemble the familiar RAT Covid test, potentially eliminating the need for long queues at PCR testing centers and drastically reducing costs to a few dollars per test. The test strips could be instrumental in rapidly responding to new pathogens, identifying areas with high antibiotic resistance, or in conservation efforts for endangered species.
The process of achieving PCR-level accuracy with these new test strips involves the creation of minuscule DNA nano-circles, each containing a fragment of the target DNA, such as the COVID virus. These nano-circles, approximately 2 nanometres in size, are then combined with CRISPR/Cas proteins, which are programmed to interact specifically with the target pathogen's DNA. When these proteins encounter the target DNA, they cause the DNA nano-circles to linearize, creating an abundance of 'fake targets.' This method triggers a molecular chain reaction, resulting in a flood of these fake targets that are easily detectable by the test strips, even with minimal presence of the original gene target.
This technology has been demonstrated to accurately detect COVID-19 virus and Helicobacter bacteria, which are responsible for stomach ulcers. Potential applications of this biosensing method extend beyond health diagnostics to include biosecurity (detecting invasive marine species), environmental science (tracking threatened species through DNA testing of environmental samples), and even cancer diagnosis, as demonstrated by the team's successful detection of cancer mutations in clinical patient samples.
“We think we created a new benchmark in biosensing – our gene-based tests will be able to be performed anywhere, anytime, by virtually anyone,” said study author Dr. Fei Deng.
Related Links:
UNSW Sydney
Latest Molecular Diagnostics News
- Blood Proteins Could Warn of Cancer Seven Years before Diagnosis
- New DNA Origami Technique to Advance Disease Diagnosis
- Ultrasound-Aided Blood Testing Detects Cancer Biomarkers from Cells
- New Respiratory Syndromic Testing Panel Provides Fast and Accurate Results
- New Synthetic Biomarker Technology Differentiates Between Prior Zika and Dengue Infections
- Novel Biomarkers to Improve Diagnosis of Renal Cell Carcinoma Subtypes
- RNA-Powered Molecular Test to Help Combat Early-Age Onset Colorectal Cancer
- Advanced Blood Test to Spot Alzheimer's Before Progression to Dementia
- Multi-Omic Noninvasive Urine-Based DNA Test to Improve Bladder Cancer Detection
- First of Its Kind NGS Assay for Precise Detection of BCR::ABL1 Fusion Gene to Enable Personalized Leukemia Treatment
- Urine Test to Revolutionize Lyme Disease Testing
- Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease
- New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk
- Blood Samples Enhance B-Cell Lymphoma Diagnostics and Prognosis
- Blood Test Predicts Knee Osteoarthritis Eight Years Before Signs Appears On X-Rays
- Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans